Carregant...

Allergische Reaktionen auf COVID-19-Impfstoffe – Evidenz und praxisorientiertes Vorgehen

Less than a year after the first detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), vaccines have been approved for routine use in numerous countries and have already been used in mass vaccination programs. Vaccines include the mRNA BNT162b2 and mRNA 1273. Allergic reactions...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Internist (Berl)
Autors principals: Klimek, L., Eckrich, J., Hagemann, J., Casper, I., Huppertz, J.
Format: Artigo
Idioma:Inglês
Publicat: Springer Medizin 2021
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7881317/
https://ncbi.nlm.nih.gov/pubmed/33580823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00108-021-00959-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!